Home | Sitemap | Search | Contact A- A A+
   
 
    Public Member Support us  
 

IBCSG 17-98 / BIG 3-97 

HABITS: Hormonal replacement therapy after breast cancer, is it safe?

DESIGN

Design Trial 17-98

Results & Publications


Publications

Study Chairs
Dr. Lars Holmberg - Uppsala, Sweden
PD Dr. Christoph Rageth - Zürich, Switzerland
Prof. Carl-Magnus Rudenstam - Göteborg, Sweden

Trial Coordinator
Melanie Schärlig-Strausak
IBCSG Coordinating Center, Bern, Switzerland
Phone: +41 31 389 93 91
Fax: +41 31 389 92 73
Email: melanie.schaerlig-strausak@ibcsg.org

Date of Activation
May 1998

Date of Closure
December 19, 2003

Targeted Accrual
1300 patients

Final Accrual
448 patients


Results Publications Results & Publications


News

27.08.2010:
Activation of IBCSG Trial 38-10/BIG 3-07/TROG 07.01

19.08.2010:
A few impressions from our audits

09.08.2010:
Latest SOLE flash

All News

 
  Print